Recent Updates
Recently added Catalysts
NTLA Neutral Sentiment

Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2023 Earnings and Company Updates

Thursday, July 27, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Intellia Therapeutics, a clinical-stage genome editing company, will hold a conference call on August 3, 2023, to discuss its financial results for the second quarter of 2023. The call will take place at 8 a.m. ET, with specific dial-in numbers provided for U.S. and international participants. A live webcast will also be available for those wishing to attend virtually. Additionally, a replay of the call will be accessible on Intellia's website following the event.
Price reaction · baseline $41.98 (2023-07-26 close) · hit after-hours · clean, no other NTLA news in the window
day 0 close · peak
-2.4%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+76%
120-day peak, hindsight
Typical move
9.6%
average across 8 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
NTLA-2002
Phase 3 · Hereditary Angioedema

Full Press Release Details

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, will present its second quarter 2023 financial results and operational highlights in a conference call on August 3, 2023, at 8 a.m. ET.
U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call.
Please visit this link for a simultaneous live webcast of the call.
A replay of the call will be available through the Events and Presentations page of the Investors & Media section on Intellia’s website at www.intelliatx.com, beginning on August 3, 2023, at 12 p.m. ET.
About Intellia Therapeutics

Frequently Asked Questions

When will Intellia Therapeutics present financial results?

Intellia Therapeutics will present its Q2 2023 financial results on August 3, 2023.

What time is the Intellia conference call scheduled?

The conference call is scheduled for 8 a.m. ET on August 3, 2023.

How can I join the Intellia conference call?

U.S. callers can dial 1-833-316-0545, and international callers should dial 1-412-317-5726.

Is there a way to watch the conference call live?

Yes, a live webcast of the conference call will be available via a provided link.

When will the call replay be available?

The call replay will be available on Intellia's website from August 3, 2023, at 12 p.m. ET.

ShareAdd on Google
Tags: NTLA Viatris Investor Conferences Healthcare Intellia Therapeutics Q2 2023 earnings call CRISPR
Last updated: Jul 27, 2023

Biotech snapshot

Cash runway
$628M liquidity · $28M/mo burn
~22 mo
Low dilution risk
Lead asset
NTLA-2002Phase 3
Hereditary Angioedema →

Catalyst track record

+76%
best trade around NTLA's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for NTLA.

See every catalyst's timing & PoA →